Formulations for benzimidazolyl pyridyl ethers

US8455662B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Ahmad Hashash · Cambridge, US
• Sean Ritchie · Fremont, US
• Kangwen L. Lin · Fremont, US
• Peng Shen · Hayward, US
• Augustus O. Okhamafe · Concord, US
• Rampurna Gullapalli · San Bruno, US

Key dates

• Filing date: Jul 20, 2007
• Grant date: Jun 4, 2013
• Expiry date: Mar 3, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Formulations are provided, comprising: a compound of Formula I, a pharmaceutically acceptable salt thereof, or a mixture of any two or more thereof; and an ingredient selected from a hydrophilic solvent, a lipophilic solvent, an emulsifier, or a mixture of any two or more thereof; wherein the compound of Formula I is:In some embodiments, the formulations are liquids. In other embodiments, the formulations are solids. Also provided are methods of preparing such formulations.